PhaseBio Pharmaceuticals to Participate in Upcoming Investor Conferences

PhaseBio

MALVERN, PA — PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiopulmonary diseases, announced that the company will be participating in two upcoming virtual investor conferences.

Details of the events are as follows:

  • Cowen 41st Annual Health Care Conference
    Date:
     March 4, 2021
    Time: 1:30 pm – 2:30 pm ET
    Chief Executive Officer, Jonathan P. Mow, is scheduled to participate in a panel discussion
  • H.C. Wainwright Global Life Sciences Conference
    Date:
     March 9, 2021
    Time: On demand beginning at 7:00 am ET
    Chief Executive Officer, Jonathan P. Mow, will present a company overview

Interested parties can access the live and archived webcasts of the virtual sessions on the “Events and Presentations” page of the “Investors” section of the company’s website at www.phasebio.com. The webcast replays will be available for 90 days after the conclusion of the live presentations.

READ:  USA Technologies Officially Launches as Cantaloupe, Inc.

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee